Bone mineral density and body composition in girls with idiopathic central precocious puberty before and after treatment with a gonadotropin-releasing hormone agonist


Autoria(s): Alessandri, Sandra B.; Pereira, Francisco de A.; Villela, Rosangela A.; Antonini, Sonir Roberto Rauber; Elias, Paula C. L.; Martinelli Jr., Carlos E.; Castro, Margaret de; Moreira, Ayrton Custodio; Paula, Francisco Jose Albuquerque de
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

24/10/2013

24/10/2013

09/02/2012

Resumo

OBJECTIVES: Idiopathic central precocious puberty and its postponement with a (gonadotropin-releasing hormone) GnRH agonist are complex conditions, the final effects of which on bone mass are difficult to define. We evaluated bone mass, body composition, and bone remodeling in two groups of girls with idiopathic central precocious puberty, namely one group that was assessed at diagnosis and a second group that was assessed three years after GnRH agonist treatment. METHODS: The precocious puberty diagnosis and precocious puberty treatment groups consisted of 12 girls matched for age and weight to corresponding control groups of 12 (CD) and 14 (CT) girls, respectively. Bone mineral density and body composition were assessed by dual X-ray absorptiometry. Lumbar spine bone mineral density was estimated after correction for bone age and the mathematical calculation of volumetric bone mineral density. CONEP: CAAE-0311.0.004.000-06. RESULTS: Lumbar spine bone mineral density was slightly increased in individuals diagnosed with precocious puberty compared with controls; however, after correction for bone age, this tendency disappeared (CD = -0.74 +/- 0.9 vs. precocious puberty diagnosis = -1.73 +/- 1.2). The bone mineral density values of girls in the precocious puberty treatment group did not differ from those observed in the CT group. CONCLUSION: There is an increase in bone mineral density in girls diagnosed with idiopathic central precocious puberty. Our data indicate that the increase in bone mineral density in girls with idiopathic central precocious puberty is insufficient to compensate for the marked advancement in bone age observed at diagnosis. GnRH agonist treatment seems to have no detrimental effect on bone mineral density.

Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP) [61398-8]

Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP)

Identificador

CLINICS, SAO PAULO, v. 67, n. 6, pp. 591-596, FEB 9, 2012

1807-5932

http://www.producao.usp.br/handle/BDPI/35952

10.6061/clinics/2012(06)08

http://dx.doi.org/10.6061/clinics/2012(06)08

Idioma(s)

eng

Publicador

HOSPITAL CLINICAS, UNIV SAO PAULO

SÃO PAULO

Relação

CLINICS

Direitos

openAccess

Copyright 2012 CLINICS

Palavras-Chave #PRECOCIOUS PUBERTY #OSTEOPOROSIS IN CHILDREN #BONE DENSITY #GONADOTROPIN-RELEASING HORMONE #SEX STEROIDS #ESTROGEN-RECEPTOR #DELAYED PUBERTY #GNRH AGONIST #MASS #CHILDREN #GROWTH #OSTEOPOROSIS #PREVENTION #GENE #MEDICINE, GENERAL & INTERNAL
Tipo

article

original article

publishedVersion